BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29706654)

  • 1. The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss.
    O'Bryant D; Wang Z
    Oncogene; 2018 Jul; 37(30):4151-4163. PubMed ID: 29706654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear transport signals control cellular localization and function of androgen receptor cofactor p44/WDR77.
    Gu Z; Zhou L; Gao S; Wang Z
    PLoS One; 2011; 6(7):e22395. PubMed ID: 21789256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization of p44/WDR77 determines proliferation and differentiation of prostate epithelial cells.
    Gao S; Wang Z
    PLoS One; 2012; 7(11):e49173. PubMed ID: 23145110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P44/WDR77 restricts the sensitivity of proliferating cells to TGFβ signaling.
    Yi P; Gao S; Gu Z; Huang T; Wang Z
    Biochem Biophys Res Commun; 2014 Jul; 450(1):409-15. PubMed ID: 24944016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
    Patel R; Gao M; Ahmad I; Fleming J; Singh LB; Rai TS; McKie AB; Seywright M; Barnetson RJ; Edwards J; Sansom OJ; Leung HY
    J Clin Invest; 2013 Mar; 123(3):1157-75. PubMed ID: 23434594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F and GATA switches turn off WD repeat domain 77 expression in differentiating cells.
    Yu M; Wang U; Wang Z
    Biochem J; 2016 Aug; 473(15):2331-43. PubMed ID: 27274086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WD Repeat Domain 77 Protein Regulates Translation of E2F1 and E2F3 mRNA.
    Altayyar MA; Sheng X; Wang Z
    Mol Cell Biol; 2020 Nov; 40(24):. PubMed ID: 33020149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.
    Zhong J; Ding L; Bohrer LR; Pan Y; Liu P; Zhang J; Sebo TJ; Karnes RJ; Tindall DJ; van Deursen J; Huang H
    Cancer Res; 2014 Mar; 74(6):1870-1880. PubMed ID: 24480624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.
    Sheng X; Bowen N; Wang Z
    Mol Cancer; 2016 Mar; 15():25. PubMed ID: 26988096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGMP-dependent protein kinase Iβ interacts with p44/WDR77 to regulate androgen receptor-driven gene expression.
    Zhou L; Hosohata K; Gao S; Gu Z; Wang Z
    PLoS One; 2014; 8(6):e63119. PubMed ID: 23755100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
    Chesire DR; Ewing CM; Gage WR; Isaacs WB
    Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation.
    Bilir B; Osunkoya AO; Wiles WG; Sannigrahi S; Lefebvre V; Metzger D; Spyropoulos DD; Martin WD; Moreno CS
    Cancer Res; 2016 Mar; 76(5):1112-21. PubMed ID: 26701805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.
    Berger PL; Frank SB; Schulz VV; Nollet EA; Edick MJ; Holly B; Chang TT; Hostetter G; Kim S; Miranti CK
    Cancer Res; 2014 Jun; 74(12):3357-68. PubMed ID: 24762396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.
    Qin T; Barron L; Xia L; Huang H; Villarreal MM; Zwaagstra J; Collins C; Yang J; Zwieb C; Kodali R; Hinck CS; Kim SK; Reddick RL; Shu C; O'Connor-McCourt MD; Hinck AP; Sun LZ
    Oncotarget; 2016 Dec; 7(52):86087-86102. PubMed ID: 27863384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer.
    Gu Z; Zhang F; Wang ZQ; Ma W; Davis RE; Wang Z
    Oncogene; 2013 Apr; 32(15):1888-900. PubMed ID: 22665061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells.
    Zhou L; Wu H; Lee P; Wang Z
    J Mol Endocrinol; 2006 Oct; 37(2):283-300. PubMed ID: 17032745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered differentiation and proliferation of prostate epithelium in mice lacking the androgen receptor cofactor p44/WDR77.
    Gao S; Wu H; Wang F; Wang Z
    Endocrinology; 2010 Aug; 151(8):3941-53. PubMed ID: 20519372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
    Lei Q; Jiao J; Xin L; Chang CJ; Wang S; Gao J; Gleave ME; Witte ON; Liu X; Wu H
    Cancer Cell; 2006 May; 9(5):367-78. PubMed ID: 16697957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
    Jiao J; Wang S; Qiao R; Vivanco I; Watson PA; Sawyers CL; Wu H
    Cancer Res; 2007 Jul; 67(13):6083-91. PubMed ID: 17616663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.